IE true 0001757898 0001757898 2023-05-03 2023-05-03 0001757898 ste:OrdinarySharesMember 2023-05-03 2023-05-03 0001757898 ste:STETwo700SeniorNotesDue2031Member 2023-05-03 2023-05-03 0001757898 ste:Two700SeniorNotesDue2051Member 2023-05-03 2023-05-03

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K/A

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 3, 2023

 

 

STERIS plc

(Exact Name of Registrant as Specified in Charter)

 

 

 

Ireland   001-38848   98-1455064
(State or Other Jurisdiction
of Incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

70 Sir John Rogerson’s Quay

Dublin 2, Ireland

(Address of Principal Executive Offices)

+353 1 232 2000

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Ordinary Shares. $0.001 par value   STE   New York Stock Exchange
2.700% Senior Notes due 2031   STE/31   New York Stock Exchange
3.750% Senior Notes due 2051   ST/51   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


EXPLANATORY NOTE

On May 3, 2023, STERIS plc (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) under Item 5.02, among others. The Original Form 8-K reported that the Board of Directors of the Company (the “Board”) increased its size from nine to ten on May 3, 2023, and elected Dr. Esther Alegria to serve as a Director effective as of that date. In accordance with the Instructions to Item 5.02 of Form 8-K, this Current Report on Form 8-K/A reports Dr. Alegria’s initial Board committee assignments. No other changes have been made to the Original Form 8-K.

 

ITEM 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 27, 2023, Dr. Esther Alegria was appointed to serve on the Compliance and Technology Committee and the Nominating and Governance Committee of the Board.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

STERIS plc
By  

/s/ J. Adam Zangerle

  J. Adam Zangerle
  Senior Vice President, General Counsel and Company Secretary

Dated: July 27, 2023

v3.23.2
Document and Entity Information
May 03, 2023
Document And Entity Information [Line Items]  
Entity Address, Country IE
Amendment Flag true
Entity Central Index Key 0001757898
Document Type 8-K/A
Document Period End Date May 03, 2023
Entity Registrant Name STERIS plc
Entity Incorporation State Country Code L2
Entity File Number 001-38848
Entity Tax Identification Number 98-1455064
Entity Address, Address Line One 70 Sir John Rogerson’s Quay
Entity Address, City or Town Dublin 2
City Area Code 353
Local Phone Number 1 232 2000
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Description On May 3, 2023, STERIS plc (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) under Item 5.02, among others. The Original Form 8-K reported that the Board of Directors of the Company (the “Board”) increased its size from nine to ten on May 3, 2023, and elected Dr. Esther Alegria to serve as a Director effective as of that date. In accordance with the Instructions to Item 5.02 of Form 8-K, this Current Report on Form 8-K/A reports Dr. Alegria’s initial Board committee assignments. No other changes have been made to the Original Form 8-K.
Ordinary Shares [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Ordinary Shares. $0.001 par value
Trading Symbol STE
Security Exchange Name NYSE
STE Two 700 Senior Notes Due 2031 [Member]  
Document And Entity Information [Line Items]  
Security 12b Title 2.700% Senior Notes due 2031
Trading Symbol STE/31
Security Exchange Name NYSE
Two 700 Senior Notes Due 2051 [Member]  
Document And Entity Information [Line Items]  
Security 12b Title 3.750% Senior Notes due 2051
Trading Symbol ST/51
Security Exchange Name NYSE

STERIS (NYSE:STE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more STERIS Charts.
STERIS (NYSE:STE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more STERIS Charts.